| 16.05 21:21 | dpa-AFX: Lancorp Launches First Trimester Preeclampsia Screening Test |
| 15.05 14:06 | dpa-AFX: *LABCORP INTRODUCES FIRST TRIMESTER SCREENING TEST TO ASSESS PREECLAMPSIA RISK DURING PREGNANCY |
| 07.05 22:06 | dpa-AFX: *INVITAE RECEIVES COURT APPROVAL FOR SALE TO LABCORP |
| 29.04 13:19 | dpa-AFX: Labcorp: FDA Approves NAbCyte Companion Diagnostic |
| 29.04 13:04 | dpa-AFX: *LABCORP: FDA APPROVES NABCYTE ANTI-AAVRH74VAR HB-FE ASSAY FOR USE WITH PFIZER'S APPROVED GENE THERAPY FOR HEMOPHILIA B |
| 25.04 20:02 | dpa-AFX: Laboratory Corporation Of America Holdings Q1 Income Climbs, But Misses Estimates |
| 25.04 14:03 | dpa-AFX: Laboratory Corporation Of America Holdings Q1 24 Earnings Conference Call At 9:00 AM ET |
| 25.04 13:25 | dpa-AFX: ROUNDUP: Labcorp Narrows FY24 Outlook Range |
| 25.04 13:15 | dpa-AFX: Laboratory Corporation Of America Holdings Q1 Income Climbs, but misses estimates |
| 25.04 13:00 | dpa-AFX: *LABCORP Q1 REVENUE $3.18 BLN 4.6% |
| 25.04 13:00 | dpa-AFX: *LABCORP Q1 ADJ. EPS RISES TO $3.68 FROM $3.46 LAST YEAR |
| 25.04 03:28 | dpa-AFX: Labcorp Wins Bid To Acquire Invitae Assets For $239 Mln Plus Non-Cash Considerations |
| 11.04 13:00 | dpa-AFX: *LABCORP DECLARES QUARTERLY CASH DIVIDEND OF $0.72/SHR; RECORD MAY 28/PAYABLE JUNE 12 |
| 10.04 13:08 | dpa-AFX: Labcorp Says FDA Grants EUA For Mpox PCR Test Home Collection Kit |
| 10.04 12:57 | dpa-AFX: *LABCORP:FDA GRANTS EUA FOR MPOX PCR TEST HOME COLLECTION KIT, FIRST AT-HOME MPOX TESTING KIT |
| 08.04 13:04 | dpa-AFX: *LABCORP ANNOUNCED STRATEGIC EXPANSION OF PRECISION ONCOLOGY PORTFOLIO |
| 05.04 13:12 | dpa-AFX: *LABCORP ANNOUNCES LAUNCH OF LABCORP® PLASMA DETECT |
| 01.04 14:21 | dpa-AFX: Labcorp Increases Strategic Investment In Xcellbio |
| 01.04 14:07 | dpa-AFX: *XCELL BIOSCIENCES EXPANDS CELL AND GENE THERAPY COLLABORATION WITH LABCORP |
| 29.03 14:05 | dpa-AFX: *PRELUDE NETWORK ANNOUNCES EXPANSION OF PARTNERSHIP WITH LABCORP |
|
|
